ArticleNPJ precision oncology2024

Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer.

Hon Yan Kelvin Yip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.